Literature DB >> 25895753

Primary Bone Lymphoma: A Clinical Analysis of 17 Patients in a Single Institution.

Eiko Hayase1, Mitsutoshi Kurosawa, Hiroaki Suzuki, Kohei Kasahara, Tomohiro Yamakawa, Masakatsu Yonezumi, Sachiko Suzuki, Takanori Teshima.   

Abstract

Primary bone lymphoma (PBL) comprises less than 1% of all malignant lymphomas. Because few studies of PBL have been conducted in Japan, the characteristics of Japanese patients with PBL have not been fully elucidated. We retrospectively analyzed 17 patients diagnosed with PBL at our institution between 2001 and 2011. Median patient age was 60 years. Eleven patients had diffuse large B-cell lymphoma and 2 patients had T-cell lymphoma histology. The spine was the most frequently involved site at the time of presentation. There were 11 patients with stage IV disease and 11 patients with high or high-intermediate risk according to the International Prognostic Index (IPI). Thirteen patients achieved complete response (CR) after initial treatment. At a median follow-up of 31 months, the 3-year overall survival (OS) and progression free survival were 63.5 and 49.9%, respectively. Localized disease, low or low-intermediate IPI, and CR after initial treatment were associated with a good outcome in patients with PBL and significantly associated with a better OS. Spine involvement and T/NK-cell phenotype are more frequent in Japanese than in Caucasian patients with PBL.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 25895753     DOI: 10.1159/000375437

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  4 in total

1.  Primary Bone Lymphoma: A 13 Year Retrospective Institutional Analysis in the Chemo-Immunotherapy Era.

Authors:  Archana Sharma; Rayaz Ahmed; Narendra Agrawal; Jyotsna Kapoor; Anurag Sharma; Vishvdeep Khushoo; Pragya Agrawal; Dinesh Bhurani; Sumeet P Mirgh
Journal:  Indian J Hematol Blood Transfus       Date:  2020-08-08       Impact factor: 0.900

2.  Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype.

Authors:  Ruben A L de Groen; Ronald van Eijk; Stefan Böhringer; Tom van Wezel; Richard Raghoo; Dina Ruano; Patty M Jansen; Inge Briaire-de Bruijn; Fleur A de Groot; Karin Kleiverda; Liane Te Boome; Valeska Terpstra; Henriette Levenga; Alina Nicolae; Eduardus F M Posthuma; Isabelle Focke-Snieders; Lizan Hardi; Wietske C E den Hartog; Lara H Bohmer; Pancras C W Hogendoorn; Anke van den Berg; Arjan Diepstra; Marcel Nijland; Pieternella J Lugtenburg; Marie José Kersten; Steven T Pals; Hendrik Veelken; Judith V M G Bovée; Arjen H G Cleven; Joost S P Vermaat
Journal:  Blood Adv       Date:  2021-10-12

3.  A case of Primary Bone Anaplastic Large Cell Lymphoma.

Authors:  Kyung Hyun Kim; Yun Hwa Jung; Chi Wha Han; In Sook Woo; Jong Ho Son
Journal:  Am J Case Rep       Date:  2016-10-12

4.  Successful Management of a Rare Case of Humerus Non-Hodgkin's Lymphoma in Rapid Progress.

Authors:  Shu-Zhong Liu; Xi Zhou; An Song; Yi-Peng Wang; Yong Liu
Journal:  Chin Med J (Engl)       Date:  2018-07-20       Impact factor: 2.628

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.